Cumberland Pharmaceuticals (CPIX) Change in Acquisitions & Divestments (2012 - 2023)
Cumberland Pharmaceuticals (CPIX) posted Change in Acquisitions & Divestments of $347356.0 for Q4 2023, up 273.68% sequentially from -$200000.0 in Q1 2021.
Cumberland Pharmaceuticals (CPIX) Change in Acquisitions & Divestments (2012 - 2023) Analysis & Trends
Cumberland Pharmaceuticals has reported Change in Acquisitions & Divestments for 11 years, with the latest figure at $347356.0 in Q4 2023.
- Quarterly Change in Acquisitions & Divestments changed N/A year-over-year to $347356.0 in Q4 2023, while the trailing twelve-month figure through Dec 2025 was $347356.0 (changed 0.0% YoY) and the FY2024 annual result came in at $237556.0, down 31.61% from the prior year.
- Change in Acquisitions & Divestments climbed to $347356.0 in Q4 2023 per CPIX's latest filing, from -$200000.0 in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $20.1 million in Q4 2019 and troughed at -$8.6 million in Q3 2019.
- A 4-year average of $3.0 million and a median of $460888.0 in 2020 frame the typical range for Change in Acquisitions & Divestments.
- The sharpest annual moves came in 2019 and 2020: Change in Acquisitions & Divestments plunged 192.9% in 2019, then surged 105.38% in 2020.
- Over 4 years, Change in Acquisitions & Divestments stood at $20.1 million in 2019, then sank by 97.7% to $460888.0 in 2020, then plunged by 143.39% to -$200000.0 in 2021, then jumped by 273.68% to $347356.0 in 2023.
- According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $347356.0, -$200000.0, and $460888.0 for Q4 2023, Q1 2021, and Q3 2020 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Cumberland Pharmaceuticals | 116.71 Mn | 112.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 347,356.00 |
| Dec 31, 2023 | 347,356.00 |
| Mar 31, 2021 | -200,000.00 |
| Mar 31, 2021 | -200,000.00 |
| Sep 30, 2020 | 460,888.00 |
| Sep 30, 2020 | 460,888.00 |
| Dec 31, 2019 | 20.06 Mn |
| Dec 31, 2019 | 20.06 Mn |
| Sep 30, 2019 | -8.56 Mn |
| Sep 30, 2019 | -8.56 Mn |
| Jun 30, 2019 | 2.08 Mn |
| Jun 30, 2019 | 2.08 Mn |
| Mar 31, 2019 | 6.48 Mn |
| Mar 31, 2019 | 6.48 Mn |
| Sep 30, 2018 | 9.22 Mn |
| Sep 30, 2018 | 9.22 Mn |
| Jun 30, 2018 | 2.65 Mn |
| Jun 30, 2018 | 2.65 Mn |
| Mar 31, 2018 | 4.26 Mn |
| Mar 31, 2018 | 4.26 Mn |